Additionally, in 2013, Mrugala et al. showed that DYRK2 protein levels are significantly reduced in high-grade glioma tissue compared to low-grade glioma tissue, suggesting its relevance in metastatic process and invasiveness potential [75]. Here, DYRK2 is linked to central nervous system cancer.